Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1070 | 969 | 1114 | 1104 | 1256 | 1685 |
Fund Return | 7.02% | -3.15% | 11.45% | 3.34% | 4.67% | 5.35% |
Place in category | 189 | 263 | 193 | 282 | 214 | 64 |
% in Category | 61 | 77 | 58 | 91 | 77 | 39 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Acatis Gane Value Event Fonds UI A | 6.52B | 10.06 | 4.18 | 6.55 | ||
Acatis Gane Value Event Fonds UI B | 6.52B | 10.48 | 4.61 | 6.99 | ||
Acatis Gane Value Event Fonds UI C | 6.52B | 8.31 | 3.85 | 6.39 | ||
ACATIS Datini Valueflex Fonds A | 791.57M | 16.27 | -1.82 | 12.18 | ||
ACATIS Datini Valueflex Fonds B | 791.57M | 15.39 | -2.65 | 11.35 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MEAG EuroInvest A | 904.98M | 10.77 | 4.02 | 7.09 | ||
MEAG EuroInvest I | 16.89M | 11.60 | 4.96 | 8.06 | ||
First Private Europa Aktien ULM B | 205.7M | 10.94 | 3.95 | 4.86 | ||
First Private Europa Aktien ULM A | 205.7M | 9.14 | 1.91 | 4.72 | ||
Allianz Vermogensbildung Europa A E | 171.32M | 2.46 | 5.15 | 4.23 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.93 | 622.6 | +5.67% | |
Novartis | CH0012005267 | 3.85 | 87.68 | +1.11% | |
Inditex | ES0148396007 | 2.73 | 49.510 | +0.14% | |
Roche Holding Participation | CH0012032048 | 2.72 | 251.00 | +1.46% | |
ASML Holding | NL0010273215 | 2.68 | 688.50 | +0.69% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review